Maryland Laser Skin and Vein Institute in Baltimore, was recently instrumental in the FDA approval of Restylane Lyft. They conducted clinical trials that proved its safety and efficacy. Dr. Robert Weiss, director of the Maryland Laser Skin and Vein Institute, was the lead investigator of the Restylane Lyft trial, which utilized the Restylane product previously called Perlane.
"We are excited that Restylane Lyft obtained FDA approval," said Dr. Robert Weiss, director of Maryland Laser Skin and Vein. "Because we participated in the clinical trials for this new product, we are now able to offer it to our regular patients with more experience than the average dermatologist. Restylane Lyft is a great filler for adding volume and lift to the cheeks, as well as for smoothing deep laugh lines."
Restylane Lyft is a hyaluronic acid gel filler which restores volume, lift, and contour to hollow or sagging cheeks, as well as reducing the appearance of nasolabial folds, also known as laugh lines. Aging causes many people to lose volume in the cheek area, causing unflattering hollows and sagging skin. In addition, deep nasolabial folds can make a person look older than they truly are. Restylane Lyft aims to reduce these concerns in a safe and non-invasive manner.
